Banner

Authors


Paul Smith

Latest:

FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.


Jacobi Cleaver, OD, FAAO

Latest:

NOA 2023: Caring for and comanaging complex cases such as squamous cell carcinoma of the conjunctiva

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on squamous cell carcinoma of the conjunctiva, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.


David S. Boyer, MD

Latest:

Advances in treatment for geographic atrophy

This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.


Charissa Lee, OD, MBA, FAAO

Latest:

VEW: Creating a contact lens culture in your practice

The Contact Lens Institute and The Vision Council presented a sneak peek of its forthcoming report, “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success,” which will be published in mid-October 2023.


Diana Chu, OD

Latest:

Comanaging tears in Descemet membrane during cataract surgery

Postoperative scenario tracks potential complications.


Kristin O. Chapman, MD

Latest:

The dropless future: SLT as a first-line treatment for glaucoma

Drop tolerance, adherence remain challenges for physicians and patients with glaucoma.


Andrew Pucker, OD, MS, PhD, FAAO

Latest:

ARVO 2023: Lexitas presents its modified NEI scale

Andrew Pucker, OD, MS, PhD, FAAO, and George Magrath, MD, discuss Lexitas Pharma Services' work on modification of the National Eye Institute's corneal fluorescein staining scale.


Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences

Latest:

9 months of COVID vaccine innovation

The speed at which the COVID-19 vaccine was developed is the medical breakthrough of our lifetimes.


Paul Hahn, MD, PhD

Latest:

Paul Hahn, MD, PhD, shares insights on pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy

Paul Hahn, MD, PhD, shared insights on research comparing the relative efficacy of pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy presented at the 2023 ASRS annual meeting.


Corporate Optometry

Latest:

Beyond the podium: Thought leadership in optometry is evolving

Corporate Optometry shares pearls on becoming a though leader in optometry.


Oliver Kuhn-Wilken
Oliver Kuhn-Wilken, OD

Latest:

A practical guide to the best of the current multifocal IOLs

Managing patient expectations is key to selecting the best lens


W. Lloyd Clark, MD

Latest:

Achieving improved outcomes through partnerships between optometrists and retina specialists

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Easy Anyama

Latest:

VEW 2023: How — and how not — to use AI in eye care

Easy Anyama shares key takeaway points from "Vision care in the age of ChatGPT" and "Advances in AI and diagnosis for BIPOC populations" at Vision Expo West 2023 in Las Vegas.


Anita Gulmiri, OD, FAAO

Latest:

AAOpt 2022: Comanagement helps elevate the full holistic standard of care for the patient

Alexis G. Malkin, OD, FAAO, and Anita Gulmiri, OD, FAAO, share highlights from their presentation, "Intersection of low vision and contact lens: unique examples of co-management," which they presented during AAOpt 2022.


Jack Phu, OD, MPH, PhD

Latest:

AAOpt 2022: Visual fields in 2022

Jack Phu, OD, MPH, PhD, with UNSW Sydney, discusses key takeaways from his AAOpt 2022 presentation that looked at visual fields in 2022.


Jennifer Tsai, OD

Latest:

VEE 2023: Starting the dual-wear conversation with patients

Jennifer Tsai, OD, tells us how to start the conversation with patients about dual-wear, and the benefits of this from the patient and provider perspective.


Alexandra Ward, VP of content

Latest:

Ocular findings of COVID-19

COVID-19 affects every part of the eye, front to back.


Gary Y. Chu, OD, MPH, FAAO

Latest:

Technology for optometry post COVID-19

ODs who utilize technology will advance modern optometric care.


Ethan Pritikin

Latest:

Don’t forget to flip the lids in keratoconus

Consider 4 conditions when treating this patient population.


Anthony Wallace

Latest:

ASCRS 2023: The introduction of SeeLuma and more

Anthony Wallace, Vice President and General Manager of the US Surgical Business at Bausch + Lomb, discussed the introduction of SeeLuma, a fully digital surgical visualization platform, and more at the 2023 ASCRS annual meeting in San Diego.


Joseph F. Panarelli, MD

Latest:

New drug delivery system aims to improve adherence

Tackle one of the biggest challenges in managing patients with glaucoma


Mike Brown, OD, MHS-CL, FAAO

Latest:

Why you should travel the extra mile for your patients

Mike Brown, OD, MHS-CL, FAAO, shares how the significance of a pocket watch and Helen Keller serve as important lessons in patient care for ODs.


Richard Meetz, OD, MS, FAAO

Latest:

The optometrist’s role in diagnosing and treating hypertension

ODs have the rare opportunity to engage as well as educate patients on hypertension.


John D. Sheppard, MD, MMSc, FACS

Latest:

Are your patients suffering in silence with dry eye disease?

By taking a proactive approach to treatment, identify the “silent sufferers.”


Jason Duncan, OD, FAAO

Latest:

Applying injection basics to your optometric practice

Jason Duncan, OD, FAAO, shares highlights from his AOA 2022 presentation, "Injection Basics," presented at this year's Optometry's Meeting in Chicago.


Kristen Brotherson

Latest:

AAOpt 2023: Pipeline update from Alcon

Hear about the new innovations on the market—and coming soon—from Alcon.



Alissa M. Coyne, OD, FAAO, FASOS

Latest:

Dr. Coyne's #1 tip for managing dry eye

Alissa M. Coyne, OD, FAAO, FASOS, gives her number 1 tip for managing dry eye.


Hattie Hayes

Latest:

Heidelberg Engineering announces FDA clearance for ANTERION diagnostic platform

The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.


© 2023 MJH Life Sciences

All rights reserved.